Effect of TEAS Combined With Oxycodone on Postoperative Visceral Pain in Gynecologic Laparoscopic Patients
Effect of Transcutaneous Electrical Acupoint Stimulation Combined With Oxycodone on Postoperative Visceral Pain and Early Recovery Quality in Gynecologic Laparoscopic Patients
Yangzhou University
120 participants
May 1, 2024
INTERVENTIONAL
Conditions
Summary
To investigate the effect and feasibility of percutaneous acupoint stimulation combined with oxycodone on postoperative visceral pain in laparoscopic patients, and provided a clinical basis for optimizing perioperative pain management in laparoscopic patients.
Eligibility
Inclusion Criteria4
- Age 18-65 years
- American Society of Anesthesiologists grade I-II
- Body mass index (BMI) 18.5-30 kg/m2;
- No ulceration or infection at the acupuncture stimulation site.
Exclusion Criteria6
- Allergic to the drugs used in the study;
- People with unclear consciousness or cognitive dysfunction;
- There are contraindications of percutaneous acupoint electrical stimulation;
- Abnormal cardiopulmonary and liver and kidney function;
- History of analgesic drug use within one week;
- History of diabetes, myocardial infarction or cerebrovascular accident.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Bilateral Neiguan point (PC6), Zusanli point (ST36) and Sanyinjiao point (SP6) were selected. Use Huatuo electronic needle therapy device, Sulodine electric stimulation hand circle TEAS, Huatuo electronic needle therapy device parameter setting: Density wave, 2/10Hz, current intensity from weak to strong, until the patient can tolerate the maximum intensity (acid, numbness, distension, pain) is appropriate, after the Sulodine brand electrical stimulation bracelet is turned on, gradually increase the stimulation intensity, until the patient can tolerate the maximum intensity is appropriate, stimulation for 30min until anesthesia induction
Oxycodone 0.1mg/kg was injected intravenously 5 minutes before anesthesia induction
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06517069